He stopped ART at the time of his first transplant, at age 40, but his viral load did not rebound. His oncologist, Dr Gero Hütter, came up with the idea of using stem cells with the CCR5-delta32 mutation, speculating that it might cure both cancer and HIV.Īs described at the 2008 Conference on Retroviruses and Opportunistic Infections (CROI), Brown first underwent intensive chemotherapy and whole-body radiation, and he developed near-fatal graft-versus-host disease. The first, Timothy Ray Brown, formerly known as the Berlin patient, received two transplants to treat leukaemia in 2006. Only a small number of people have been cured of HIV after stem cell transplants. The man, who wishes to remain anonymous, added, “When I was diagnosed with HIV in 1988, like many others, I thought it was a death sentence, I never thought I would live to see the day that I no longer have HIV.” A handful of stem cell cures But now, he can celebrate this medical milestone.” “He saw many of his friends die from AIDS in the early days of the disease and faced so much stigma when he was diagnosed with HIV in 1988. “The ability to use partially matched umbilical cord blood grafts greatly increases the likelihood of finding suitable donors for such patients.“We were thrilled to let him know that his HIV is in remission and he no longer needs to take antiretroviral therapy that he had been on for over 30 years,” Dickter said in a City of Hope press release. who could benefit from this procedure," Koen van Besien, director of the stem cell transplant program at Weill Cornell Medicine and one of the doctors involved in the treatment, tells the Guardian’s Maya Yang. "We estimate that there are approximately 50 patients per year in the U.S. The recent treatment is part of a larger study that will follow a total of 25 people with HIV who receive cord blood stem cell transplants for the treatment of their cancer, and will likely initially only apply to those with aggressive cancers like leukemia, per reporters at Healthline. All three patients that appear to be cured of HIV also had cancer and needed a stem cell transplant to save their lives, per Reuters.ĭespite the apparent success of the treatment, it won’t be available to most of the 38 million people living with HIV around the world just yet. Unlike the complications that both Brown and Castillejo suffered after their bone marrow transplants, the patient left the hospital 17 days after her procedure without any signs of graft versus host disease. “The fact that she’s mixed race, and that she’s a woman, that is really important scientifically and really important in terms of the community impact,” Steven Deeks, an AIDS expert at the University of California, San Francisco who was not involved in the work, tells the Times. Cord blood donors don’t need to be matched as closely to the recipient as bone marrow donors, so it can be an option for patients with uncommon tissue types. This was the first case of HIV treatment using umbilical cord blood, which is less invasive and more widely available than invasive bone marrow transplants that cured the two male patients. According to doctors, the woman, who is keeping her identity private, has now been free of the virus for 14 months. When the female patient needed umbilical cord blood as a treatment for leukemia, her doctors chose a donor with natural immunity to HIV with the hope of helping her fight both illnesses. Those stem cells develop into all types of blood cells that support the immune system. Both bone marrow and umbilical cord blood, which is collected at the time of a baby's birth and donated by parents, contain adult hematopoietic stem cells. Instead of using stem cells from umbilical cord blood, Timothy Brown and Adam Castillejo received a bone marrow transplant from donors with a genetic mutation that blocks HIV infection, reports Nicoletta Lanese for Live Science. Two previous patients that appear to have been cured of HIV, the virus that causes AIDS, underwent a different treatment. The success of the new method involving umbilical cord blood could allow doctors to help more people of diverse genders and racial backgrounds, Apoorva Mandavilli reports for the New York Times. A woman of mixed race is the third person in the world believed to be cured of HIV after receiving a stem cell transplant from a donor naturally resistant to the virus, scientists announced last week.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |